Impact of hereditary thrombophilia on cancer-associated thrombosis, tumour susceptibility and progression: A review of existing evidence
V Tavares, BV Neto, MI Vilas-Boas, D Pereira… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Venous thromboembolism (VTE) is a cardiovascular disorder frequently diagnosed among
cancer patients. Aside from being common, VTE severely deteriorates the prognosis of these …
cancer patients. Aside from being common, VTE severely deteriorates the prognosis of these …
Underlying Mechanisms of Thrombosis Associated with Cancer and Anticancer Therapies
D Pantazi, D Alivertis, AD Tselepis - Current Treatment Options in …, 2024 - Springer
Opinion Statement Cancer-associated thrombosis (CAT) has been identified as the second
most prevalent cause of death after cancer itself. Moreover, the risk of thrombotic events in …
most prevalent cause of death after cancer itself. Moreover, the risk of thrombotic events in …
Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta‐analysis
In the general population, individuals with an inherited thrombophilia have a higher risk of
thrombosis, but the effect of inherited thrombophilia on the risk of cancer‐associated venous …
thrombosis, but the effect of inherited thrombophilia on the risk of cancer‐associated venous …
Genes and proteins associated with the risk for cancer-associated thrombosis
JT Buijs, HH Versteeg - Thrombosis Research, 2020 - Elsevier
Cancer patients have a four-to sevenfold increased risk of developing cancer-associated
thrombosis (CAT), which is associated with a strong increase in morbidity and mortality. Not …
thrombosis (CAT), which is associated with a strong increase in morbidity and mortality. Not …
Haemostatic gene variations in cervical cancer-associated venous thrombosis: considerations for clinical strategies
BV Neto, V Tavares, JB da Silva, J Liz-Pimenta… - Journal of Thrombosis …, 2024 - Springer
Venous thromboembolism (VTE) is a life-threatening haemostatic disease frequently
diagnosed among the cancer population. The Khorana Score is currently the primal risk …
diagnosed among the cancer population. The Khorana Score is currently the primal risk …
The association of the prothrombin A19911G single-nucleotide polymorphism and the risk of venous thromboembolism: A systematic review and meta-analysis
K Xiang, H Xu, Y Zhang, Q Leng, F Zhang - Phlebology, 2024 - journals.sagepub.com
Background The study employed meta-analysis to provide a comprehensive synthesis of
evidence regarding the association between the prothrombin A19911G polymorphism and …
evidence regarding the association between the prothrombin A19911G polymorphism and …
The efficacy of tissue factor− 603A/G and+ 5466A> G polimorphisms at the development of venous thromboembolism in cancer patients
Background and Aim: Venous thromboembolism (VTE) is one of the most common
complications in cancer patients. Although factor V Leiden (FVL) is the most common …
complications in cancer patients. Although factor V Leiden (FVL) is the most common …
Thrombosis and bleeding in cancer patients
W Korte - The MASCC textbook of cancer supportive care and …, 2018 - Springer
Cancer patients show a hypercoagulable state with a high risk for thrombosis and
pulmonary embolism, due to the malignancy itself as well as various therapies used. Real …
pulmonary embolism, due to the malignancy itself as well as various therapies used. Real …